Clinical trial
A Community Population Screening Cohort Study Based on Polygene Methylation Detection for Colorectal Cancer in Yangzhou
NCT05336539 is registered in ClinicalTrials.gov with Singlera Genomics Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Community Population Screening Cohort Study Based on Polygene Methylation Detection for Colorectal Cancer in Yangzhou
- Lead sponsor
- Singlera Genomics Inc.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 1, 2022
- Completion date
- April 30, 2027
- Enrollment
- 80,000 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer